Increasing Patent Allowance Rate Using an Optimized Invention Management Solution

Huge sums of time and money are invested to support ongoing research and development efforts globally, particularly in the most innovative industries like pharma, healthcare and biotechnology. The global R&D spending [1] is at a record high of US$1.7 trillion of which 80% of total spending is only from the Top 10 countries. While these statistics may suggest increased intensity of companies in R&D spending, we should also understand that these efforts will only yield returns when they are awarded enforceable ownership through exclusive patent rights. Intellectual property rights, especially patents, help companies protect their business interests by allowing them to

Continue reading »

Acquisition and Predictive Analysis

It’s been a busy year for mergers and acquisitions, with a number of billion dollar deals that happened. We tracked and analyzed over 700 Mergers & Acquisitions that occurred in 2017 and extracted the 20 largest deals across 9 industries, valued above $5 B. $274.9B in large M&A transactions took place in 2017. 42% of the transactions occurred in the Medical/Pharma Sector totaling $86.6 B across 8 events. 21% of the transactions occurred in the Energy Sector totaling $28.3 B across 4 events. The largest acquisition in the most active sector: Medical equipment/Pharma was J&J | Actelion at $30B. The largest acquisition

Continue reading »

6 Signs That Your Invention Management Solution Is Strained

Is my invention management solution rational? As an IP Counsel, you already know from experience how crucial the invention disclosure is, as is having a scalable and future-ready Invention Management Solution (IMS) in place, because the destiny of a patent starts right from its conception. You probably have a system in place, whether internally developed or a third-party application, to manage your invention disclosure cycle. Gone are those days when the complete disclosure process was managed through emails, spreadsheets, Kanban boards and other methods. There are many good web-based applications out there that enable management of  your entire disclosure process;

Continue reading »

Is your patent getting the life it deserves?

Patent Term Adjustments (PTAs) alter the patent term and are meant to account for delays in patent prosecution, and usually increase the life of the patent beyond their normal 20 year term. They are usually calculated by accounting for prosecution delays by both the applicant and the USPTO. The PTO automatically grants adjustments, but patentees can petition to recalculate the adjustment if they disagree with the PTO’s calculation. In our own experience, USPTO miscalculations, though rare, can be quite significant. In some of these cases, recalculation led to an addition of several hundred days to the life of the patent.

Continue reading »

5 Ways Symphony Can Help Your Company Attract and Maintain Top-Tier Inventors

“An enterprise that is constantly exploring new horizons is likely to have a competitive advantage in attracting and retaining talent.”  Gary P. Hamel Management Expert Founder of Strategos The world is trending toward automation, and intellectual property (IP) management is no exception. Symphony is designed to streamline IP lifecycle management processes to reduce costs, improve efficiency, and eliminate administrative errors. If your company has an extensive IP portfolio, Symphony not only will reduce your overhead and simplify portfolio management, but it will also help attract top-tier inventors who understand the value of working with an organized, reliable enterprise. Let’s explore

Continue reading »

Artificial Intelligence Innovation: A Case Study

by Deepa R. Krishna and Mark O’Donnell Introduction: The artificial intelligence (AI) landscape is growing quickly.  Artificial intelligence startups raised $5B in 2016, a 10-fold increase since 2012.[1]  Tech giants (Google, Microsoft, IBM) are contributing heavily to this acceleration, both in academic and practical pursuits.  Google published 218 papers on machine learning in 2016, nearly double the number of publications in 2014.[2]  In December 2016, Microsoft launched a new venture fund specifically to evaluate and fund AI startups, kicking off the fund with an investment in Element AI, then acquiring Maluuba just one month later. [3] [4] For professional advisors

Continue reading »

MaxVal Patent Litigation Databank expands coverage to include Global Patent Litigation Data

MaxVal, a leading technology-enabled IP solutions provider known for its cutting edge products and automated solutions announces the global data expansion of MaxVal’s Litigation Databank with the inclusion of valuable non-US litigation data. MaxVal’s Litigation Databank is an exhaustive collection of litigation data including cases of US District Courts, Court of Appeals for the Federal Circuit, International Trade Commission, Supreme Court and PTAB (Patent Trial and Appeal Board). MaxVal’s Litigation data already provide insights for some of the leading patent analytics providers including WIPS, IP.com, PatSnap.com and Aistemos as well as industry innovators such as Unified Patents. MaxVal’s global patent

Continue reading »

MaxVal Sponsors and Exhibits at IP Counsel Cafe – May 10-12, 2017

MaxVal is sponsoring the upcoming IP Counsel Café, one of the largest annual gathering of IP Counsel and professionals, May 10-12, 2017 in Palo Alto, CA. MaxVal will showcase its suite of IP lifecycle management solutions to the IP Counsel and IP Portfolio managers. As an exhibiting sponsor, MaxVal will demonstrate their end-to-end Intellectual Asset Management solution, Symphony and participate in various networking opportunities throughout the event. From invention capture, docketing to annuity management, Symphony brings all facets of IP management onto one stage. “We are excited that since its launch, Symphony has been trusted by more than 20 SMBs and Fortune

Continue reading »

Best Practices for a Comprehensive Post-Allowance Review

When a Notice of Allowance (NOA) is received by the Applicant, it means that a patent application will no longer be reviewed by the examiner and it is entitled to the patent under the law. In other words, an application is about to be issued after the prosecution phase. However, the NOA may have errors or data missing, failing to correct them at this critical stage may impact the quality and the enforceability of the patent. Depending on the severity of the issue, an RCE may need to be filed to make necessary corrections or even defer or withdraw patent

Continue reading »